Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001393905-12-000379
Filing Date
2012-07-16
Accepted
2012-07-16 17:23:20
Documents
12
Period of Report
2012-02-29

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT trab_10k.htm 10-K 493108
2 CONSULTING AGREEMENT trab_ex104.htm EX-10.4 66227
3 CONSULTING AGREEMENT trab_ex105.htm EX-10.5 138797
4 SEPARATION AGREEMENT trab_ex106.htm EX-10.6 10121
5 CERTIFIICATION trab_ex311.htm EX-31.1 7758
6 CERTIFIICATION trab_ex321.htm EX-32.1 4336
  Complete submission text file 0001393905-12-000379.txt   2180257

Data Files

Seq Description Document Type Size
7 trab-20120229.xml EX-101.INS 208356
8 trab-20120229.xsd EX-101.SCH 12066
9 trab-20120229_cal.xml EX-101.CAL 5740
10 trab-20120229_def.xml EX-101.DEF 67733
11 trab-20120229_lab.xml EX-101.LAB 108702
12 trab-20120229_pre.xml EX-101.PRE 80734
Mailing Address 120 WALL STREET SUITE 2401 NEW YORK NY 10005
Business Address 120 WALL STREET SUITE 2401 NEW YORK NY 10005 866-284-9561
TheraBiogen, Inc. (Filer) CIK: 0001405286 (see all company filings)

EIN.: 980559606 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-53008 | Film No.: 12964303
SIC: 2834 Pharmaceutical Preparations